Mettler-Toledo International (MTD) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
18 Mar, 2026Executive summary
Annual meeting scheduled for May 7, 2026, at 8:00 AM ET in New York.
Proxy materials and 2025 Annual Report are available online for review and voting.
Shareholders can request paper or electronic copies of proxy materials at no charge.
Voting matters and shareholder proposals
Election of nine directors is on the agenda, with board recommending a vote FOR all nominees.
Ratification of the independent registered public accounting firm is proposed.
Advisory vote to approve executive compensation is included, with board recommending FOR.
Board of directors and corporate governance
Board recommends all director nominees for election at the annual meeting.
Director nominees include Roland Diggelmann, Domitille Doat-Le Bigot, Elisha W. Finney, Pablo Perversi, Thomas P. Salice, Brian Shepherd, Michael J. Tokich, Wolfgang Wienand, and Ingrid Zhang.
Latest events from Mettler-Toledo International
- Annual meeting covers director elections, auditor ratification, and performance-based executive pay.MTD
Proxy Filing18 Mar 2026 - Q4 2025 saw 8% sales and EPS growth, with a strong 2026 outlook despite market headwinds.MTD
Q4 20256 Feb 2026 - Q2 sales fell 4%, but margin gains and service growth led to raised full-year guidance.MTD
Q2 20242 Feb 2026 - Q3 adjusted EPS up 4% on 1% sales growth; Laboratory and Service led gains amid soft markets.MTD
Q3 202415 Jan 2026 - Manufacturing flexibility, innovation, and operational programs drive growth and margin expansion.MTD
Stifel 2024 Healthcare Conference13 Jan 2026 - Innovation, digitalization, and margin expansion fuel global growth and shareholder value.MTD
44th Annual J.P. Morgan Healthcare Conference13 Jan 2026 - Lab and service growth offset China industrial softness; cautious 2025 outlook with service focus.MTD
7th Annual Evercore ISI HealthCONx Conference11 Jan 2026 - Innovation, digitalization, and service drive growth, with margin expansion and 2025 recovery expected.MTD
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Q4 2024 saw double-digit sales and EPS growth, with 2025 guidance reflecting ongoing headwinds.MTD
Q4 20248 Jan 2026